Search
for
Sort by
Research 751–780 of 1000+
- Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants
- COVID-19: Evaluation and Care of Patients With Persistent Symptoms Following Acute SARS-CoV-2 Infection
- A case of severe autoimmune hemolytic anemia after a receipt of a first dose of SARS‐CoV‐2 vaccine
- In silico screening of Moroccan medicinal plants with the ability to directly inhibit the novel coronavirus, SARS-CoV-2
- Associations between sampling characteristics, nutritional supplemental taking and the SARS-CoV-2 infection onset in a cohort of Italian nurses
- Non‐invasive instrumental examinations of cutaneous, adnexal and mucosal manifestations after SARS‐COV‐2 infection in adult and children
- New product intros (finasteride/tadalafil (new combination); sutimlimab; human SARS-CoV-2 recombinant nanoparticle vaccine, adjuvanted with AS03; bupropion hydrochloride/dextromethorphan hydrobromide (new combination))
- Olive oil regenerates the hair lost during the alopecia complication caused through SARS Co-2 infection as well as with vaccination
- Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals
- Diffused alopecia followed by severe acute respiratory syndrome coronavirus-2 infection
- Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?
- The role of androgens in COVID-19
- The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic
- Clinical symptoms of hyperandrogenic women diagnosed with COVID‐19
- Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
- COVID ‐19 induced telogen effluvium
- Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
- Risks of alopecia areata in long COVID: Binational population‐based cohort studies from South Korea and Japan
- COVID-19 Infection: Impact on Hair
- Association between alopecia areata and COVID-19: A systematic review
- Alopecia and severity of COVID-19: a cross-sectional study in Peru
- Comment on “Androgenetic alopecia present in the majority of patients hospitalized with COVID-19”
- Cepharanthine: A review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Impact of anti-androgen therapies on COVID-19 susceptibility: a case-control study in male population from two COVID-19 regional centers of Lombardy (Italy)
- The significance of coronavirus infection in the development of reproductive and lower urinary tract lesions
- Not just thinning: A case of alopecia universalis after mild COVID-19
- A response to “Male balding is a major risk factor for severe COVID-19”
- Reply to the Letter to the Editor “Androgen deprivation therapy may constitute a more effective prophylactic than therapeutic strategy in COVID-19 patients” by N. Bennani and I. M. Bennani-Baiti
- Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin
- PO.8.170 Drug-induced lupus or systemic lupus erythematosus after experimental COVID-19 therapy: difficulties in differential diagnosis